Clinical outcomes: propensity score-matched cohort
| Outcomes | EVT (n=184) | No EVT (n=184) | OR (95% CI) | P values |
| Primary outcome | ||||
| mRS score 0–2 at 90 days, n (%) | 105 (57.1) | 60 (32.6) | 2.74 (1.79 to 4.19) | <0.0001 |
| Secondary outcomes | ||||
| mRS score 0–1 at 90 days, n (%) | 66 (35.9) | 40 (21.7) | 2.01 (1.26 to 3.19) | 0.003 |
| Mortality at 90 days, n (%) | 7 (3.8) | 12 (6.5) | 0.56 (0.21 to 1.47) | 0.34 |
| Safety outcomes | ||||
| Intracranial hemorrhage within 72 hours, n (%) | 51 (27.7) | 55 (29.9) | 0.83 (0.53 to 1.31) | 0.48 |
| Symptomatic intracranial hemorrhage within 72 hours, n (%) | 7 (3.8) | 9 (4.9) | 0.72 (0.26 to 2.00) | 0.61 |
EVT, endovascular therapy; mRS, modified Rankin Scale.